跳至主要内容
临床试验/KCT0004206
KCT0004206尚未招募不适用

Analysis of Prognostic factors and Biomarkers for the prediction of systemic therapies including tyrosine kinase inhibitors and immunotherapy response in patients with locally advanced hepatocellular carcinoma

Seoul National University Hospital0 个研究点目标入组 400 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
18(Year) 至 80(Year)(—)
性别
All

入选标准

  • Patients with histologically confirmed locally advanced or metastatic HCC, which was judged not to be eligible for surgical resection, liver transplantation or radiofrequency ablation

排除标准

  • Patients with histologically confirmed fibrolamellar type HCC or combined type with cholangiocarcinoma
  • Patients who refuse to participate in the study

研究者

相似试验